Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2850
Selected: 0
NCT IDTitle
NCT01368783Two Clinical Trials to Evaluate Pharmacokinetics of Unboosted and Boosted Atazanavir Used Alone or Co-administered With Tenofovir DF in Healthy Korean and Caucasian Male Volunteers
NCT00000954A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma
NCT03189069A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage
NCT01594554A 5-year Observational Follow-up Study to Describe Treatment Patterns in Real World of HCV Patients in China.
NCT02393794Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)
NCT06153251A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
NCT03808441CAcTUS - Circulating Tumour DNA Guided Switch
NCT01614756A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic Dermatitis
NCT01018745Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan
NCT07101094Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
NCT01995266Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual
NCT00971945Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast Cancer
NCT01022801A Phase II Dose Response Study in Japan in Chronic Hepatitis B
NCT02743494An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer
NCT05162222A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Single-dose of Danicamtiv in Healthy Participants
NCT04109131A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours
NCT05582395A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy
NCT02250001Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis C
NCT02960230H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas
NCT00162240PPAR - Combination With Metformin
NCT02762123A Study to Assess the Effect of BMS-986142 on Pharmacokinetics (PK) of Probe Substrates
NCT00216203Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer
NCT00420186A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin
NCT02464969Apixaban for the Acute Treatment of Venous Thromboembolism in Children
NCT05005273A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer
NCT00392769Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer
NCT00343317Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women
NCT01986218Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumors
NCT05088889Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer
NCT01632150Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
NCT07361289A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
NCT06794268A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
NCT03098550A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread
NCT03355560Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy
NCT03681561Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
NCT03224260To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants
NCT03317327REirradiation and Programmed Cell Death Protein 1 (PD-1) Blockade On Recurrent Squamous Cell Head and Neck Tumors
NCT03879122A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer
NCT01105429Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes
NCT02739386Study of Autoimmune Disease Complications Following Ipilimumab Treatment Among Melanoma Patients With Underlying Autoimmune Diseases
NCT06268886Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease
NCT01235351Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56
NCT00519831Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC
NCT00770302Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of Saxagliptin
NCT00565773Belatacept Post Depletional Repopulation to Facilitate Tolerance
NCT04124003A Study to Assess the Drug-drug Interaction of BMS-963272 and Rosuvastatin
NCT06710470A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring
NCT00561964Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria
NCT04810078A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread
NCT05577715A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC)